Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males†: Profile Report

By Garnock-Jones Karly P.  

Drugs in R&D, Vol. 12, Iss. 4, 2012-12 ,pp. : 235-238

Adis International

Access to resources Recommend Favorite

Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®): A Review of its Use in the Prevention of Premalignant Genital Lesions, Genital Cancer and Genital Warts in Women

By McCormack Paul L.  

Drugs, Vol. 70, Iss. 18, 2010-12 ,pp. : 2449-2474

Adis International

Access to resources Recommend Favorite

Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil ® )

By Siddiqui M. Asif A.   Perry Caroline M.  

Drugs, Vol. 66, Iss. 9, 2006-01 ,pp. : 1263-1271

Adis International

Access to resources Recommend Favorite

Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®): A Viewpoint by Daron G. Ferris

By Ferris Daron G.  

Drugs, Vol. 66, Iss. 9, 2006-01 ,pp. : 1272-1273

Adis International

Access to resources Recommend Favorite

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

By McKeage Kate  

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 465-468

Adis International

Access to resources Recommend Favorite